| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Oct 29, 2025 | Oct 31, 2025 | BridgeBio Pharma, Inc. | Director | Sell | 7.5 | -198,359 | -20.63% | ✓ | $13.2M |
| Oct 27, 2025 | Oct 29, 2025 | BridgeBio Pharma, Inc. | Director | Sell | 50.0 | -1,641 | -0.17% | ✓ | $106.7K |
| Sep 5, 2025 | Sep 8, 2025 | BridgeBio Pharma, Inc. | Director | Sell | 17.5 | -74,000 | -7.13% | ✗ | $3.9M |
| Jun 24, 2025 | Jun 26, 2025 | BridgeBio Pharma, Inc. | Director | Sell | 23.8 | -100,000 | -9.41% | ✓ | $4.4M |
| Dec 26, 2023 | Dec 28, 2023 | BridgeBio Pharma, Inc. | Director | Sell | 23.8 | -100,000 | -8.33% | ✓ | $4.2M |
| Nov 13, 2020 | Nov 17, 2020 | BridgeBio Pharma, Inc. | Chair | Sell | 17.5 | -100,000 | -7.69% | ✗ | $4.3M |
| Dec 27, 2019 | Dec 31, 2019 | BridgeBio Pharma, Inc. | Chair | Sell | 42.5 | -100,000 | -0.77% | ✓ | $3.8M |